---
figid: PMC11011631__ijms-25-03876-g001
pmcid: PMC11011631
image_filename: ijms-25-03876-g001.jpg
figure_link: /pmc/articles/PMC11011631/figure/ijms-25-03876-f001/
number: Figure 1
figure_title: ''
caption: The figure represents the HER2 signalling pathway and the extra- and intra-cellular
  binding site of anti-HER2 drugs. HER2 receptor is composed of four extracellular
  domains identified as I, III, III, and IV.
article_title: 'Targeting HER2 in Gastroesophageal Adenocarcinoma: Molecular Features
  and Updates in Clinical Practice.'
citation: Maria Bonomi, et al. Int J Mol Sci. 2024 Apr;25(7):3876.
year: '2024'

doi: 10.3390/ijms25073876
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- gastroesophageal adenocarcinoma
- HER2
- immunotherapy
- trastuzumab
- trastuzumab deruxtecan
- ct-DNA
- heterogeneity

---
